Birkeland KI, Bodegard J, Banerjee A, Kim DJ, et al. Lower Cardiorenal Risk with Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study. Diabetes Obes Metab 2020 Sep 7. doi: 10.1111/dom.14189.
PMID: 32893440